Managing the complexity of a global single-use supply chain for vaccine manufacturing

 Single-use systems have been proven to enable a more flexible, cost-effective approach to manufacturing monoclonal antibodies (mAbs), cell and gene therapies, and other complex biologics. In vaccine manufacturing, specifically, single-use solutions can facilitate
multi-product manufacturing in order to increase capacity and reduce cost. Underestimating
the regulatory, manufacturing and quality requirements for single-use products required for vaccine production as well as the complexities of a global vaccines supply chain can leave a company unable to quickly meet growing global demand. In this presentation, learn why it’s important to adopt a global single use supply chain strategy as part of the early stages of a vaccine product lifecycle, with a case study demonstrating how innovative single-use solutions can both support supply chain security and enhance efficiencies in vaccine manufacturing
processes.